VRTX

VERTEX PHARMACEUTICALS INC / MA · Wikipedia · Yahoo Finance chart ↗

Price

Last close: $558.88Last update Oct 30, 2026
12-month high: $563.80
12-month low: $403.16

Reported holders

Politicians whose newest complete holdings report lists this stock, or who reported buying it after that report (or at any time, if they have no usable report). A later full sale that could have closed the position removes them.

Name	Purchased	Price that day	ROI
Alan Armstrong	Mar 27, 2026	$433.07	+29.05%
Harriet M. Hageman	Held as of Dec 31, 2025 (holdings report)	Not available	Not available
Gilbert Cisneros Rank #23	Held as of Dec 31, 2025 (holdings report)	Not available	Not available
Rob Bresnahan Rank #94	Held as of Dec 31, 2025 (holdings report)	Not available	Not available
Julie Johnson Rank #41	Held as of Dec 31, 2025 (holdings report)	Not available	Not available
Julia Letlow Rank #8	Oct 23, 2024	$470.05	+18.90%
William R. Keating Rank #117	Mar 29, 2022	$257.98	+116.64%

Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close. Holders listed from a holdings report alone have no purchase date, so no price or ROI.

All trades

Public-equity transactions, newest transaction dates first
Ticker	Politician Name	Transaction Type	Trade Date	Found Date
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], David J. Taylor, sale, Aug 26, 2026	David J. Taylor Rank #55	Sale	Aug 26, 2026	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock, Alan Armstrong, purchase, Mar 27, 2026	Alan Armstrong	Purchase	Mar 27, 2026	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], David J. Taylor, sale, Jan 29, 2026	David J. Taylor Rank #55	Sale	Jan 29, 2026	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], David J. Taylor, purchase, Aug 7, 2025	David J. Taylor Rank #55	Purchase	Aug 7, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Lisa McClain, sale, Jun 11, 2025	Lisa McClain Rank #2	Sale	Jun 11, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Lisa McClain, sale, Jun 10, 2025	Lisa McClain Rank #2	Sale	Jun 10, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Jefferson Shreve, sale, May 12, 2025	Jefferson Shreve Rank #124	Sale	May 12, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Byron Donalds, sale, Mar 20, 2025	Byron Donalds Rank #47	Sale	Mar 20, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Jefferson Shreve, purchase, Mar 13, 2025	Jefferson Shreve Rank #124	Purchase	Mar 13, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Jefferson Shreve, purchase, Feb 24, 2025	Jefferson Shreve Rank #124	Purchase	Feb 24, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Lisa McClain, purchase, Dec 11, 2024	Lisa McClain Rank #2	Purchase	Dec 11, 2024	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Julia Letlow, purchase, Oct 23, 2024	Julia Letlow Rank #8	Purchase	Oct 23, 2024	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock, Thomas H Tuberville, sale, May 3, 2024	Thomas H Tuberville Rank #111	Sale	May 3, 2024	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated (VRTX) [ST], Greg Stanton, sale, Oct 24, 2023	Greg Stanton Rank #88	Sale	Oct 24, 2023	Sep 12, 2026
VRTX — Vertex Pharmaceuticals Incorporated (VRTX) [ST], Greg Stanton, purchase, Sep 26, 2023	Greg Stanton Rank #88	Purchase	Sep 26, 2023	Sep 12, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock, Thomas H Tuberville, purchase, Oct 6, 2022	Thomas H Tuberville Rank #111	Purchase	Oct 6, 2022	Sep 12, 2026
VRTX — Vertex Pharmaceuticals Incorporated (VRTX) [ST], William R. Keating, purchase, Mar 29, 2022	William R. Keating Rank #117	Purchase	Mar 29, 2022	Sep 12, 2026